Common Protocol Mistakes We've Seen Over the years, our team has consulted on countless research projects, and we've seen a few common missteps that can inadvertently sabotage results
Liana K Billings et al, Eloralintide, a selective amylin receptor agonist for the treatment of obesity: a 48-week phase 2, multicentre, double-blind, randomised, placebo-controlled trial, The Lancet, 2025, Kirsten Dahl et al, NN1213-A Potent, Long-Acting, and Selective Analog of Human Amylin, J
In DIO rats, sub-chronic administration of 0833 and 0839 profoundly reduced food intake and body weight, and both potentiated semaglutide's effects on food intake and body weight to an equal extended
GHK-Cu also activates more than 4,000 genes involved in tissue repair and turns off genes associated with inflammation and fibrosis